NOVN

Novan, Inc. Common Stock

NOVN

Market cap $2.64M

Overview Fund Trends Analyst Outlook Journalist POV

Delisted

NOVN was delisted on the 25th of July, 2023.

Back to rankings

Positive

Neutral

Negative

Sentiment 3-Months

Positive

Neutral 0%

Negative

This Pharma Giant Will Invest $23 Billion in the U.S. It's a Sign Trump's Tariffs Are Working.

The Company spend billions to produce 100% of its key medicines for Americans in the U.S.

This Pharma Giant Will Invest $23 Billion in the U.S. It's a Sign Trump's Tariffs Are Working.

Novartis has cash for a big pharma deal—but here's why it's not buying

Novartis AG (SWX: NOVN) has the cash to opt for a large deal in pursuit of accelerated growth – but it's just not interested in one, according to its chief executive Vasant Narasimhan. That's because the bigger deals have historically not paid off in the pharmaceutical sector.

Novartis has cash for a big pharma deal—but here's why it's not buying

How Novartis plans to thrive without competing directly with Eli Lilly in weight loss drug market

As weight-loss treatments dominate the pharmaceutical market, Swiss drugmaker Novartis AG (SWX: NOVN) is choosing a different path. While competitors like Eli Lilly and Novo Nordisk race to capture the booming weight-loss drug market, Novartis is steering clear of the frenzy.

How Novartis plans to thrive without competing directly with Eli Lilly in weight loss drug market

See News Rankings